Yes—underbilling is the primary driver of Plastic Surgery EBITDA loss in New York, not claim denials or slow collections. The proof? New York plastic surgery practices with 95%+ clean claim rates and <30 Days in AR still lose 18–28% of potential revenue ($1.2M–$3.8M annually for practices collecting $1M–$5M+ monthly) because performed procedures never generate charges, […]
Is Underbilling Driving Plastic Surgery EBITDA Loss in New York?









